Startseite/Aktien/NPCE

NPCE

USD

Neuropace Inc. Common Stock

$11.230-0.570 (-4.831%)

Echtzeitkurs

Healthcare

Medizinprodukte

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$11.800

Hoch

$12.032

Tief

$11.110

Volumen

0.24M

Unternehmensfundamentaldaten

Marktkapitalisierung

368.3M

Branche

Medizinprodukte

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.29M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $5.45Aktuell $11.230Hoch $18.975

Ähnliche Nachrichten

4. Juni 2025 · 20:09

GlobeNewswire

NeuroPace Secures Up to $75 Million in Debt Financing

MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has

NeuroPace Secures Up to $75 Million in Debt Financing

28. Mai 2025 · 10:27

Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On NeuroPace with Buy Rating, Announces Price Target of $18

HC Wainwright & Co. analyst Yi Chen initiates coverage on NeuroPace with a Buy rating and announces Price Target of $18.

HC Wainwright & Co. Initiates Coverage On NeuroPace with Buy Rating, Announces Price Target of $18

27. Mai 2025 · 12:00

GlobeNewswire

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study met the 12-week